These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

451 related items for PubMed ID: 18942060

  • 21. Long-term outcome of transcatheter patent foramen ovale closure in patients with paradoxical embolism.
    Cifarelli A, Musto C, Parma A, Pandolfi C, Pucci E, Fiorilli R, De Felice F, Nazzaro MS, Violini R.
    Int J Cardiol; 2010 Jun 11; 141(3):304-10. PubMed ID: 19178959
    [Abstract] [Full Text] [Related]

  • 22. Causes of recurrent focal neurologic events after transcatheter closure of patent foramen ovale with the CardioSEAL septal occluder.
    Kutty S, Brown K, Asnes JD, Rhodes JF, Latson LA.
    Am J Cardiol; 2008 May 15; 101(10):1487-92. PubMed ID: 18471463
    [Abstract] [Full Text] [Related]

  • 23. Late results after percutaneous closure of patent foramen ovale for secondary prevention of paradoxical embolism using the amplatzer PFO occluder without intraprocedural echocardiography: effect of device size.
    Wahl A, Tai T, Praz F, Schwerzmann M, Seiler C, Nedeltchev K, Windecker S, Mattle HP, Meier B.
    JACC Cardiovasc Interv; 2009 Feb 15; 2(2):116-23. PubMed ID: 19463412
    [Abstract] [Full Text] [Related]

  • 24. The Closure of Patent Foramen Ovale in Preventing Subsequent Neurological Events: A Bayesian Network Meta-Analysis to Identify the Best Device.
    Varotto L, Bregolin G, Paccanaro M, De Boni A, Bonanno C, Perini F.
    Cerebrovasc Dis; 2020 Feb 15; 49(2):124-134. PubMed ID: 32289794
    [Abstract] [Full Text] [Related]

  • 25. Persistent venous valves correlate with increased shunt and multiple preceding cryptogenic embolic events in patients with patent foramen ovale: an intracardiac echocardiographic study.
    Rigatelli G, Dell'avvocata F, Braggion G, Giordan M, Chinaglia M, Cardaioli P.
    Catheter Cardiovasc Interv; 2008 Dec 01; 72(7):973-6. PubMed ID: 19021284
    [Abstract] [Full Text] [Related]

  • 26. Propensity Score-Based Analysis of Percutaneous Closure Versus Medical Therapy in Patients With Cryptogenic Stroke and Patent Foramen Ovale: The IPSYS Registry (Italian Project on Stroke in Young Adults).
    Pezzini A, Grassi M, Lodigiani C, Patella R, Gandolfo C, Zini A, DeLodovici ML, Paciaroni M, Del Sette M, Toriello A, Musolino R, Calabrò RS, Bovi P, Adami A, Silvestrelli G, Sessa M, Cavallini A, Marcheselli S, Marco Bonifati D, Checcarelli N, Tancredi L, Chiti A, Del Zotto E, Tomelleri G, Spalloni A, Giorli E, Costa P, Giacalone G, Ferrazzi P, Poli L, Morotti A, Piras V, Rasura M, Simone AM, Gamba M, Cerrato P, Zedde ML, Micieli G, Melis M, Massucco D, Guido D, De Giuli V, Bonaiti S, D'Amore C, La Starza S, Iacoviello L, Padovani A, Italian Project on Stroke in Young Adults (IPSYS) Investigators.
    Circ Cardiovasc Interv; 2016 Sep 01; 9(9):. PubMed ID: 27582111
    [Abstract] [Full Text] [Related]

  • 27. Interventional closure of patent foramen ovale with Nit-occlud® device in prevention of recurrent neurologic events-Long-term results.
    Araszkiewicz A, Sławek S, Trojnarska O, Lesiak M, Grygier M.
    Catheter Cardiovasc Interv; 2018 Jul 01; 92(1):159-164. PubMed ID: 29068141
    [Abstract] [Full Text] [Related]

  • 28. Transcatheter patent foramen ovale closure for secondary prevention of paradoxical embolic events: acute results from the FORECAST registry.
    Alameddine F, Block PC.
    Catheter Cardiovasc Interv; 2004 Aug 01; 62(4):512-6. PubMed ID: 15274163
    [Abstract] [Full Text] [Related]

  • 29. Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism: procedural and follow-up results after implantation of the Amplatzer®-occluder device.
    Fischer D, Haentjes J, Klein G, Schieffer B, Drexler H, Meyer GP, Schaefer A.
    J Interv Cardiol; 2011 Feb 01; 24(1):85-91. PubMed ID: 20735710
    [Abstract] [Full Text] [Related]

  • 30. Transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Procedural and follow-up results after implantation of the Starflex occluder device with conjunctive intensified anticoagulation regimen.
    Fischer D, Fuchs M, Schaefer A, Schieffer B, Jategaonkar S, Hornig B, Drexler H, Meyer GP.
    J Interv Cardiol; 2008 Apr 01; 21(2):183-9. PubMed ID: 18312307
    [Abstract] [Full Text] [Related]

  • 31. Another addition to the tool box.
    Tuzcu EM.
    Catheter Cardiovasc Interv; 2008 May 01; 71(6):829-30. PubMed ID: 18412080
    [No Abstract] [Full Text] [Related]

  • 32. A propensity score-matched comparison between Cardia and Amplatzer PFO closure devices - insights from the SOLUTION registry (Swiss percutaneOus patent foramen ovale cLosUre in recurrent clinical events prevenTION).
    Puricel S, Arroyo D, Goy JJ, Praz F, Palhais N, Wahl A, Stauffer JC, Togni M, Berger A, Meier B, Cook S.
    EuroIntervention; 2015 Jun 01; 11(2):230-7. PubMed ID: 24830681
    [Abstract] [Full Text] [Related]

  • 33. Percutaneous closure of patent foramen ovale in cryptogenic embolism.
    Meier B, Kalesan B, Mattle HP, Khattab AA, Hildick-Smith D, Dudek D, Andersen G, Ibrahim R, Schuler G, Walton AS, Wahl A, Windecker S, Jüni P, PC Trial Investigators.
    N Engl J Med; 2013 Mar 21; 368(12):1083-91. PubMed ID: 23514285
    [Abstract] [Full Text] [Related]

  • 34. Transcatheter closure of patent foramen ovale in patients with cryptogenic stroke.
    Butera G, Bini MR, Chessa M, Bedogni F, Onofri M, Carminati M.
    Ital Heart J; 2001 Feb 21; 2(2):115-8. PubMed ID: 11256538
    [Abstract] [Full Text] [Related]

  • 35. Transseptal puncture to facilitate device closure of "long-tunnel" patent foramen ovale.
    Thompson AJ, Hagler DJ, Taggart NW.
    Catheter Cardiovasc Interv; 2015 May 21; 85(6):1053-7. PubMed ID: 25380406
    [Abstract] [Full Text] [Related]

  • 36. Interventional closure with Amplatzer PFO occluder of patent foramen ovale in patients with paradoxical cerebral embolism.
    Chatterjee T, Petzsch M, Ince H, Rehders TC, Körber T, Weber F, Schneider H, Auf der Maur C, Nienaber CA.
    J Interv Cardiol; 2005 Jun 21; 18(3):173-9. PubMed ID: 15966921
    [Abstract] [Full Text] [Related]

  • 37. PFO and paradoxical embolism producing events other than stroke.
    Dao CN, Tobis JM.
    Catheter Cardiovasc Interv; 2011 May 01; 77(6):903-9. PubMed ID: 21207422
    [Abstract] [Full Text] [Related]

  • 38. Transcatheter PFO closure with GORE(®) septal occluder: early and mid-term clinical results.
    Butera G, Saracino A, Danna P, Sganzerla P, Chessa M, Carminati M.
    Catheter Cardiovasc Interv; 2013 Nov 15; 82(6):944-9. PubMed ID: 23897659
    [Abstract] [Full Text] [Related]

  • 39. Transcatheter Closure of Patent Foramen Ovale in Older Patients With Cryptogenic Thromboembolic Events.
    Alperi A, Guedeney P, Horlick E, Nombela-Franco L, Freixa X, Pascual I, Mesnier J, Houde C, Abrahamyan L, Montalescot G, Rodés-Cabau J.
    Circ Cardiovasc Interv; 2022 Jul 15; 15(7):e011652. PubMed ID: 35735021
    [Abstract] [Full Text] [Related]

  • 40. Management of residual shunts after initial percutaneous patent foramen ovale closure: a single center experience with immediate and long-term follow-up.
    Diaz T, Cubeddu RJ, Rengifo-Moreno PA, Cruz-Gonzalez I, Solis-Martin J, Buonanno FS, Inglessis I, Palacios IF.
    Catheter Cardiovasc Interv; 2010 Jul 01; 76(1):145-50. PubMed ID: 20578100
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.